TY - JOUR AU - Galiè, N. AU - Hinderliter, A. L. AU - Torbicki, A. AU - Fourme, T. AU - Simonneau, G. AU - Pulido, T. PY - 2003 DA - 2003// TI - Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension JO - J Am Coll Cardiol. VL - 41 UR - https://doi.org/10.1016/S0735-1097(03)00121-9 DO - 10.1016/S0735-1097(03)00121-9 ID - Galiè2003 ER - TY - JOUR AU - Galiè, N. AU - Seeger, W. AU - Naeije, R. AU - Simonneau, G. AU - Rubin, L. J. PY - 2004 DA - 2004// TI - Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension JO - J Am Coll Cardiol. VL - 43 UR - https://doi.org/10.1016/j.jacc.2004.02.038 DO - 10.1016/j.jacc.2004.02.038 ID - Galiè2004 ER - TY - JOUR AU - Humbert, M. AU - Sitbon, O. AU - Simonneau, G. PY - 2004 DA - 2004// TI - Treatment of pulmonary arterial hypertension JO - N Engl J Med. VL - 351 UR - https://doi.org/10.1056/NEJMra040291 DO - 10.1056/NEJMra040291 ID - Humbert2004 ER - TY - JOUR AU - Galiè, N. AU - Humbert, M. AU - Vachiery, J. L. AU - Vizza, C. D. AU - Kneussl, M. AU - Manes, A. PY - 2002 DA - 2002// TI - Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial JO - J Am Coll Cardiol. VL - 39 UR - https://doi.org/10.1016/S0735-1097(02)01786-2 DO - 10.1016/S0735-1097(02)01786-2 ID - Galiè2002 ER - TY - JOUR AU - Farber, H. W. AU - Loscalzo, J. PY - 2004 DA - 2004// TI - Pulmonary arterial hypertension JO - N Engl J Med. VL - 351 UR - https://doi.org/10.1056/NEJMra035488 DO - 10.1056/NEJMra035488 ID - Farber2004 ER - TY - JOUR AU - Galiè, N. AU - Olschewski, H. AU - Oudiz, R. J. AU - Torres, F. AU - Frost, A. AU - Ghofrani, H. A. PY - 2008 DA - 2008// TI - Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2 JO - Circulation. VL - 117 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.742510 DO - 10.1161/CIRCULATIONAHA.107.742510 ID - Galiè2008 ER - TY - JOUR AU - Humbert, M. AU - Sitbon, O. AU - Chaouat, A. AU - Bertocchi, M. AU - Habib, G. AU - Gressin, V. PY - 2010 DA - 2010// TI - Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era JO - Circulation. VL - 122 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.911818 DO - 10.1161/CIRCULATIONAHA.109.911818 ID - Humbert2010 ER - TY - JOUR AU - Barst, R. J. AU - Ivy, D. D. AU - Gaitan, G. AU - Szatmari, A. AU - Rudzinski, A. AU - Garcia, A. E. PY - 2012 DA - 2012// TI - A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension JO - Circulation. VL - 125 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.016667 DO - 10.1161/CIRCULATIONAHA.110.016667 ID - Barst2012 ER - TY - JOUR AU - Oudiz, R. J. AU - Brundage, B. H. AU - Galiè, N. AU - Ghofrani, H. A. AU - Simonneau, G. AU - Botros, F. T. PY - 2012 DA - 2012// TI - Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study JO - J Am Coll Cardiol. VL - 60 UR - https://doi.org/10.1016/j.jacc.2012.05.004 DO - 10.1016/j.jacc.2012.05.004 ID - Oudiz2012 ER - TY - JOUR AU - Galiè, N. AU - Manes, A. AU - Negro, L. AU - Palazzini, M. AU - Bacchi-Reggiani, M. L. AU - Branzi, A. PY - 2009 DA - 2009// TI - A meta-analysis of randomized controlled trials in pulmonary arterial hypertension JO - Eur Heart J. VL - 30 UR - https://doi.org/10.1093/eurheartj/ehp022 DO - 10.1093/eurheartj/ehp022 ID - Galiè2009 ER - TY - JOUR AU - Hoeper, M. M. AU - Barberia, J. A. AU - Channick, R. N. AU - Hassoun, P. M. AU - Lang, I. M. AU - Manes, A. PY - 2009 DA - 2009// TI - Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension JO - J Am Coll Cardiol. VL - 54 UR - https://doi.org/10.1016/j.jacc.2009.04.008 DO - 10.1016/j.jacc.2009.04.008 ID - Hoeper2009 ER - TY - JOUR AU - Rich, S. PY - 2007 DA - 2007// TI - The value of approved therapies for pulmonary arterial hypertension JO - Am Heart J. VL - 153 UR - https://doi.org/10.1016/j.ahj.2007.03.001 DO - 10.1016/j.ahj.2007.03.001 ID - Rich2007 ER - TY - JOUR AU - Chen, S. L. AU - Zhang, F. F. AU - Xu, J. AU - Xie, D. J. AU - Zhou, L. AU - Nguyen, T. PY - 2013 DA - 2013// TI - Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 Study (First-in-Man Pulmonary Artery Denervation for Treatment of Pulmonary Artery Hypertension) JO - J Am Coll Cardiol. VL - 62 UR - https://doi.org/10.1016/j.jacc.2013.05.075 DO - 10.1016/j.jacc.2013.05.075 ID - Chen2013 ER -